WallStreetZenWallStreetZen

NASDAQ: MYMD
Mymd Pharmaceuticals Inc Stock

$2.40-0.10 (-4%)
Updated Apr 12, 2024
MYMD Price
$2.40
Fair Value Price
$1.71
Market Cap
$5.18M
52 Week Low
$2.07
52 Week High
$70.50
P/E
-0.45x
P/B
0.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$4.00M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.41
Operating Cash Flow
-$13M
Beta
1.49
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MYMD Overview

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MYMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MYMD ($2.40) is overvalued by 40.64% relative to our estimate of its Fair Value price of $1.71 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MYMD ($2.40) is not significantly undervalued (40.64%) relative to our estimate of its Fair Value price of $1.71 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MYMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MYMD due diligence checks available for Premium users.

Be the first to know about important MYMD news, forecast changes, insider trades & much more!

MYMD News

Valuation

MYMD fair value

Fair Value of MYMD stock based on Discounted Cash Flow (DCF)
Price
$2.40
Fair Value
$1.71
Overvalued by
40.64%
MYMD ($2.40) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MYMD ($2.40) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MYMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MYMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.45x
Industry
14.72x
Market
42.64x

MYMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
5.93x
MYMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MYMD's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.4M
Profit Margin
0%
MYMD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$17.9M
Liabilities
$5.1M
Debt to equity
0.41
MYMD's short-term assets ($5.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MYMD's short-term assets ($5.82M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MYMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MYMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.9M
Investing
$5.9M
Financing
-$1.6M
MYMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MYMD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MYMD$5.18M-4.00%-0.45x0.42x
TCBP$5.14M-6.94%-0.07x1.49x
GNPX$5.12M-3.60%-0.12x0.69x
SNPX$5.09M-2.88%-0.16x0.21x
MBIO$5.28M-7.13%-0.08x42.91x

Mymd Pharmaceuticals Stock FAQ

What is Mymd Pharmaceuticals's quote symbol?

(NASDAQ: MYMD) Mymd Pharmaceuticals trades on the NASDAQ under the ticker symbol MYMD. Mymd Pharmaceuticals stock quotes can also be displayed as NASDAQ: MYMD.

If you're new to stock investing, here's how to buy Mymd Pharmaceuticals stock.

What is the 52 week high and low for Mymd Pharmaceuticals (NASDAQ: MYMD)?

(NASDAQ: MYMD) Mymd Pharmaceuticals's 52-week high was $70.50, and its 52-week low was $2.07. It is currently -96.6% from its 52-week high and 15.94% from its 52-week low.

How much is Mymd Pharmaceuticals stock worth today?

(NASDAQ: MYMD) Mymd Pharmaceuticals currently has 2,157,632 outstanding shares. With Mymd Pharmaceuticals stock trading at $2.40 per share, the total value of Mymd Pharmaceuticals stock (market capitalization) is $5.18M.

Mymd Pharmaceuticals stock was originally listed at a price of $61,055.95 in Jan 24, 2014. If you had invested in Mymd Pharmaceuticals stock at $61,055.95, your return over the last 10 years would have been -100%, for an annualized return of -63.74% (not including any dividends or dividend reinvestments).

How much is Mymd Pharmaceuticals's stock price per share?

(NASDAQ: MYMD) Mymd Pharmaceuticals stock price per share is $2.40 today (as of Apr 12, 2024).

What is Mymd Pharmaceuticals's Market Cap?

(NASDAQ: MYMD) Mymd Pharmaceuticals's market cap is $5.18M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mymd Pharmaceuticals's market cap is calculated by multiplying MYMD's current stock price of $2.40 by MYMD's total outstanding shares of 2,157,632.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.